Europe
AstraZeneca’s Imfinzi wins EU approval for aggressive form of lung cancer
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8,…
